Company intelligence / Profile preview

Haemnet

United Kingdom

Ownership: Private
Development stage: Other

Overview

Haemnet is a specialist research and communications consultancy working in the bleeding disorders community. The company conducts natural history studies and patient research, including the Glanzmann's 360 study and Von Willebrand Disease 360 study, to understand disease burden and patient experiences. These studies support pharmaceutical companies in developing treatments for rare bleeding disorders.

Therapeutic areas: Hematology
Industry: Consulting

Partnerships

Hemab Therapeutics

Beyond the preview

Go deeper on Haemnet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haemnet.

Explore the full profile